Pharmacogenomics Collaboration, Education, and Resources

Pharmacogenomics Collaboration, Education, and Resources

Pharmacogenomics (PGx), or the study of how a patient’s genetic code may impact their response to medication and treatment, is a growing area of patient care. While physicians can be great champions and resources for patients interested in PGx, they are often one member of a larger Pharmacogenomics-focused care team. By effectively communicating PGx concepts through education and resources, providers can help convey information about PGx to patients and other health care providers.

  • Provider:American Medical Association
  • Activity Link: https://edhub.ama-assn.org/ama-pharmacogenomics-summit-series/interactive/18690086
  • Start Date: 2022-04-21 05:00:00
  • End Date: 2022-04-21 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.25 hours
  • MOC Credit Details: ABS - 0.25 Point; Credit Type(s): Accredited CME (ABS)
    ABPATH - 0.25 Point; Credit Type(s): Lifelong Learning (ABPATH)
    ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
    ABP - 0.25 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
    ABOHNS - 0.25 Point; Credit Type(s): Self-Assessment (ABOHNS)
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Competence, Learner Knowledge
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: All Practice Areas (e.g. ethics), General Otolaryngology, General Pediatrics, General Surgery, Internal Medicine
«
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.